Poor ovarian response is reported in 9–24% of IVF cycles. Several interventions have been proposed to improve the outcome, although evidence to support these has been scant. There has been interest in the use of adjuvant androgens in this context and a recent worldwide survey showed that nearly a quarter of IVF clinicians used dehydroepiandrosterone (DHEA) in poor responders. We examine the rationale for the use of adjuvant androgens and suggest that the current clinical uncertainty should be addressed by a randomized controlled trial of DHEA in poor responders.
- poor ovarian response
- IVF treatment
Sunkara, S. K., Coomarasamy, A., Arlt, W., & Bhattacharya, S. (2012). Should androgen supplementation be used for poor ovarian response in IVF? Human Reproduction, 27(3), 637-640. https://doi.org/10.193/humrep/der464